NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Anadys Pharmaceuticals Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
2009 MAY 4 ... Keywords: Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Anadys Pharmaceuticals Inc., Antiviral Activity, Clinical Trial Research, Gastroenterology, HCV, Hepatitis C Virus, ...
Subject: Hepatitis C Virus
Price: $3.00
*
ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients
2009 AUG 24 ... Keywords: Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Anadys Pharmaceuticals Inc., Antiviral, Clinical Trial Research, Drug Development, Gastroenterology, HCV, Hepatitis ...
Subject: Hepatitis C Virus
Price: $3.00
*
Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
2009 SEP 21 ... ANA598 when used in combination with interferon and ribavirin." Keywords: Anadys Pharmaceuticals Inc., Clinical Trial Research, Drugs, Enzyme Research, Gastroenterology, HCV, Hepatitis C ...
Subject: Hepatitis C Virus
Price: $3.00
*
Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
2009 AUG 10 ... duration of HCV therapy in conjunction with ANA598 treatment." Keywords: Anadys Pharmaceuticals Inc., Antineoplastic, Antiviral, Clinical Trial Research, Copegus, Drugs, FDA, ...
Subject: Interferon
Price: $3.00
*
Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
2009 AUG 10 ... by year-end 2009 and additional data in the first half of 2010." Keywords: Anadys Pharmaceuticals Inc., Biopharmaceuticals, Chronic Hepatitis C, Drugs, FDA, Gastroenterology, HCV, Hepatitis ...
Subject: Hepatitis C Virus
Price: $3.00
*
Anadys Pharmaceuticals Reports Third Quarter 2009 Financial Results and Program Highlights
2009 NOV 9 ... both cohorts in the study during the first half of next year." Keywords: Anadys Pharmaceuticals Inc., Biopharmaceuticals, Drugs, Gastroenterology, HCV, Hepatitis C Virus, Hepatology, ...
Subject: Pharmaceuticals
Price: $3.00
*
Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
2009 APR 6 ... webcast concludes and will be available through April 16, 2009. Keywords: Anadys Pharmaceuticals Inc., Cancer, Gastroenterology, HCV, Hepatitis C Virus, Hepatology, Infectious Disease, ...
Subject: Anadys Pharmaceuticals, Inc.
Price: $3.00
*
Anadys Pharmaceuticals to Present at the Citi Biotech Day
2009 APR 6 ... webcast concludes and will be available through April 15, 2009. Keywords: Anadys Pharmaceuticals Inc., Gastroenterology, HCV, Hepatitis C Virus, Hepatology, Infectious Disease, ...
Subject: Pharmaceuticals
Price: $3.00
*
Anadys Pharmaceuticals to present at the JMP Securities Healthcare Focus Conference
2009 OCT 12 ... webcast concludes and will be available through October 19, 2009. Keywords: Anadys Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
2009 NOV 9 ... concludes and will be available through November 18, 2009. Keywords: Anadys Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
2009 SEP 14 ... conclude and will be available through September 25, 2009. Keywords: Anadys Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
2009 MAY 4 ... and telephone replay will be available through May 7, 2009. Keywords: Anadys Pharmaceuticals Inc., Antiviral, Pharmaceutical Business, Pharmaceutical Company, Treatment, Viral ...
Subject: Pharmaceuticals
Price: $3.00
*
Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
2009 AUG 3 ... and telephone replay will be available through August 13, 2009. Keywords: Anadys Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
Anadys Pharmaceuticals to Report Third Quarter 2009 Financial Results
2009 NOV 2 ... and telephone replay will be available through November 12, 2009. Keywords: Anadys Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering
2009 JUN 15 ... in which such offer, solicitation or sale is unlawful. Keywords: Anadys Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
2009 JUN 15 ... conducted at a number of clinical sites in the United States. Keywords: Anadys Pharmaceuticals Inc., Antiviral Activity, Clinical Trial Research, Drugs, Gastroenterology, HCV, Hepatitis C ...
Subject: Hepatitis C Virus
Price: $3.00
*
California Healthcare Institute Board Elects George Scangos as Vice Chairman
2009 MAY 18 ... of Frank Ruddle, Ph.D., at Yale University. Currently, Scangos serves as chairman of Anadys Pharmaceuticals and he serves on the board of the following organizations: Visitors of ... that George A. Scangos, Ph.D., president and chief executive officer, Exelixis, Inc., was elected to serve as CHI’s vice chairman. CHI is a non-profit public policy ...
Subject: California Healthcare Institute
Price: $3.00
*
Data on life sciences discussed by researchers at Anadys Pharmaceuticals, Inc., Department of Biology
2009 MAY 4 ... Oaks, CA 91320, USA. Keywords: United States, San Diego, Life Sciences, Anadys Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company, Biomolecular Screening. ...
Subject: Life Sciences
Price: $3.00
*
Hepatitis C Virus and Therapeutics - Global Strategic Business Report
2009 JUN 8 ... many key and niche players such as Abbott Diagnostics, Achillion Pharmaceuticals, Inc., Anadys Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, F. ...
Subject: Research and Markets
Price: $3.00
*
Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors
2009 SEP 14 ... issues in the biomedical and life sciences. He is a member of the Board of Directors of Anadys Pharmaceuticals, Inc. and of the Biotechnology Industry Organization (BIO), and a ...
Subject: Neurodegenerative Disease
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login